What is the VIS date for vaccines?
Vaccine Information Statements for Currently Available VaccinesVISCurrent Edition DatesPrevious Edition DatesZoster / Shingles (Recombinant)2/4/222/4/21 10/30/19 2/12/18Multi Vaccine VIS (DTaP, IPV, HepB, PCV, Hib)10/15/214/1/20 11/5/15Multi VIS (DTaP, IPV, HepB, PCV, Hib, Rotavirus)–11/16/12 9/18/08 1/30/0834 more rows
What is the VIS and when must it be given to the patient guardian?
You must provide a current VIS before a vaccine is administered to the patient. A VIS provides information about the disease and the vaccine and must be given to the patient before a vaccine is administered.
What is a VIS report?
Vaccine Information Statements (VISs) are information sheets produced by the CDC that explain both the benefits and risks of a vaccine to vaccine recipients. Federal law requires that healthcare staff provide a VIS to a patient, parent, or legal representative before each dose of certain vaccines.
What is the VIS date for Pneumovax 23?
This page was updated on January 7, 2021. This page was reviewed on October 30, 2019....TRANSLATIONS OF THE APRIL 24, 2015 PNEUMOCOCCAL POLYSACCHARIDE VACCINE VIS.ArmenianHmongPunjabiCambodian (Khmer)JapaneseTagalogFarsiKhmer (Cambodian)2 more rows•Jan 7, 2021
What is the minimum interval between the first and second doses of either Havrix or Vaqta?
Vaccination Schedule and Use The second dose of Vaqta is administered 6 through 18 months after the first dose, and the second dose of Havrix is administered 6 through 12 months after the first dose.
What is RA 10152 all about?
Republic Act No. 10152 has been signed. It is otherwise known as the “Mandatory Infants and Children Health Immunization Act of 2011, which requires that all children under five years old be given basic immunization against vaccine-preventable diseases.
What does vis mean in medical terms?
What's a VIS? A VIS or Vaccine Information Statement is a document, produced by CDC, that informs vaccine recipients – or their parents or legal representatives – about the benefits and risks of a vaccine they are receiving.
Where would you go to get the most current version of all vis?
www.immunize.org/visIf you have out- dated VISs, get current versions at www.immunize.org/vis. Check your supply of VISs against this list. If you have out- dated VISs, get current versions at www.immunize.org/vis.
How long is PNEUMOVAX 23 Good For?
The Pneumovax 23 covers twenty three different variants of the pneumococcal bacteria. In healthy adults, revaccination is not indicated (necessary). Patients with underlying chronic disease should probably be revaccinated every 5 years. An annual flu shot (influenza vaccine) is probably also indicated.
Should you get Both Prevnar 13 and PNEUMOVAX 23?
ACIP recommends that both PCV13 and PPSV23 be given in series to adults aged ≥65 years. A dose of PCV13 should be given first followed by a dose of PPSV23 at least 1 year later to immunocompetent adults aged ≥65 years. The two vaccines should not be co-administered.
How often do you need PNEUMOVAX 23?
The recommended interval is at least 1 year. The minimum interval is 8 weeks and can be considered in adults with an immunocompromising condition*, cochlear implant, or cerebrospinal fluid leak.
Is PNEUMOVAX 23 given every 5 years?
CDC recommends you: The first dose of PPSV23 should be given at least 8 weeks after any prior PCV13 dose, then the second dose of PPSV23 should be given at least 5 years after the first dose of PPSV23.
How long is Pneumovax good for out of fridge?
This vaccine is very stable both alone and in combination with other vaccine components. It must be refrigerated at temperatures below 4 C at which temperature, it slowly deteriorates after two years. At room temperature, it retains its stability at 25 C for up to one month.
How many pneumonia shots do you need after 65?
All adults 65 and older need two pneumococcal shots: the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23). Some adults who are 19 to 64 will need two pneumococcal shots - both PCV13 and PPSV23.
What are the indications for PNEUMOVAX 23?
Indication for PNEUMOVAX 23 PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged ≥2 years who are at increased risk for pneumococcal disease. PNEUMOVAX 23 will not prevent disease caused by capsular types of pneumococcus other than those contained in the vaccine.